Evidence map›Paper›PMID 35882499›Full record

ArticleBlood advances2022

A starting point for the phenotypic classification of pulmonary chronic graft-versus-host disease.

Yifan Pang, Ananth V Charya, Michael B Keller, Arlene Sirajuddin, Yi-Ping Fu, Noa G Holtzman, Steven Z Pavletic, Sean Agbor-Enoh

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Yifan PangHematology and Medical Oncology.ORCID 0000-0002-8934-8251
Ananth V CharyaPulmonary Branch, National Heart, Lung, and Blood Institute (NHLBI), and.ORCID 0000-0002-9366-1515
Michael B KellerCritical Care Medicine Department, Clinical Center, National Institutes of Health (NIH), Bethesda, MD.
Arlene SirajuddinDepartment of Radiology and Imaging Sciences, NIH Clinical Center, Bethesda, MD.
Yi-Ping FuOffice of Biostatistics Research, NHLBI.
Noa G HoltzmanImmune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, and.ORCID 0000-0002-5706-1109
Steven Z PavleticImmune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, and.
Sean Agbor-EnohDepartment of Pulmonary and Critical Care Medicine, Johns Hopkins Hospital, Baltimore, MD.

Funding

NIH Chronic GVHD Study GroupZIABC011743 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI PAVLETIC, STEVEN · 2016 to 2025
$10.2M
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationHumansTransplantation, Homologous

Identifiers

PMID35882499
PMCPMC9631627

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.